1. Wang, Yan-Na, Zhou, Xu-Jie, Chen, Pei, Lv, Ji-Cheng, Zhang, Hong. 2021. Interaction between GALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy. In Journal of the American Society of Nephrology : JASN, 32, 545-552. doi:10.1681/ASN.2020060823. https://pubmed.ncbi.nlm.nih.gov/33593824/
2. Seguí, Nuria, Pineda, Marta, Navarro, Matilde, Capellá, Gabriel, Valle, Laura. 2013. GALNT12 is not a major contributor of familial colorectal cancer type X. In Human mutation, 35, 50-2. doi:10.1002/humu.22454. https://pubmed.ncbi.nlm.nih.gov/24115450/
3. Yu, Site, Feng, Wenjie, Zeng, Jizhang, Peng, Yinghua, Zhang, Pihong. 2023. GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization. In Oncology letters, 26, 543. doi:10.3892/ol.2023.14131. https://pubmed.ncbi.nlm.nih.gov/38020290/
4. Zheng, Yongjia, Liang, Minting, Wang, Bowen, Mao, Yang, Wang, Shengjun. 2022. GALNT12 is associated with the malignancy of glioma and promotes glioblastoma multiforme in vitro by activating Akt signaling. In Biochemical and biophysical research communications, 610, 99-106. doi:10.1016/j.bbrc.2022.04.052. https://pubmed.ncbi.nlm.nih.gov/35461073/
5. Guda, Kishore, Moinova, Helen, He, Jian, Gerken, Thomas A, Markowitz, Sanford D. 2009. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. In Proceedings of the National Academy of Sciences of the United States of America, 106, 12921-5. doi:10.1073/pnas.0901454106. https://pubmed.ncbi.nlm.nih.gov/19617566/
6. Clarke, Erica, Green, Roger C, Green, Jane S, Younghusband, H Banfield, Woods, Michael O. 2012. Inherited deleterious variants in GALNT12 are associated with CRC susceptibility. In Human mutation, 33, 1056-8. doi:10.1002/humu.22088. https://pubmed.ncbi.nlm.nih.gov/22461326/
智鼠故事 
